October 3, 2011
Novartis Pharma launched the COPD treatment Onbrez Inhalation Capsules 150 µg (indacaterol maleate) on September 20. Data released by Chuikyo forecasts peak sales of ¥11.5 billion in FY2020. Of the company’s 2,250 MRs, a majority of those in the fields...read more